Form D · Biotechnology
Diag-Nose Medical Pty Ltd
Salter Point, Western Australi, C3 · CIK 0001846642
Offering snapshot reported Mar 1, 2021 · SEC filing
- Reported sold
- $263K Offering amount: $263K
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 8, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 1, 2021 | Initial | $263,447 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-390825
Converted to USD from AUD$330,300 on spot price for February 25, 2021.
No sales commissions or Finder's Fees have been or are intended to be paid in connection with this offering.
Source: Form D, filed Mar 1, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Shaikh Salah El Din | Executive |
| Brian Shih Ning Wang | Director, Executive |
| David Melicio Yen | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4 Redmond Street
Salter Point, Western Australi, C3, 6152
Salter Point, Western Australi, C3, 6152